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Stem cell and differentiated cell lines derived from transplantable murine terato- 
carcinomas have been established in tissue culture by several methods (1-6) and have 
been  characterized as nullipotent, pluripotent, and  terminally differentiated.  Pluri- 
potent  stem  cells show  remarkable similarities to  the  pluripotent  cells of the  early 
embryo  and  the  stem  cells  of one  particularly  well  studied  teratocarcinoma,  the 
OTT6050 tumor established by Stevens (7), have been shown to be totipotent because 
single stem cells from this tumor have been injected into blastocysts of mice and the 
offspring derived from injected blastocysts have been shown  to be mosaic in most, if 
not all, tissues, including the germ line (8). Cells derived from stem cell lines carried 
in  tissue culture  for  many  generations  are  also  able  to  participate in  formation  of 
normal tissue in mosaic mice (9,  10, 6). 
Thus,  pluripotent  or  totipotent  stem  cell  lines  and  the  differentiated  cell  lines 
derived from  them  have great potential for the study of differences in regulation of 
gene expression in embryonic versus differentiated cells. It has already been demon- 
strated that stem and differentiated cell lines do indeed respond differently to infection 
with  oncogenic  viruses.  Stem  cell  lines  are  resistant  to  infection  with  DNA  tumor 
viruses (11,  12)  and murine C-type viruses (13,  14), and this resistance is not a  result 
of lack of penetration of these viruses (15,  14). 
We have established (6) stem cell and differentiated cell lines from a  murine strain 
129 testicular teratocarcinoma, OTT6050, which had been carried as a solid tumor in 
strain  129 mice before these studies. The stem and differentiated cell lines have been 
characterized for their interaction with murine leukemia virus and the stem cells have 
been found to be nonpermissive for productive infection by Moloney leukemia virus 
(Mo-MuLV) 1 in accordance with  the results of others.  However, each  of the differ- 
entiated lines established from this OTT6050 tumor was found to be producing an N- 
tropic murine leukemia virus which closely resembles N-tropic AKR  MuLV  and the 
stem cell line carries DNA sequences homologous to this N-tropic virus which are not 
expressed as viral proteins or infectious virus in stem cells. 
* Supported in part by grant VC 220 from the American Cancer Society, by U.S. Public Health Service 
research grants  CA  16885, CA 20741, CA 21069, and CA  21124 from the National Cancer Institute, 
RR05540 from the Division of Research Resources, and GM 20700 from the Institute of General Medical 
Sciences, and by grant 1-522 from the National Foundation--March of Dimes. 
:1: Recipient of Research Career Development Award CA 00143 from the National Cancer Institute. 
i Abbreviations used in this paper." BrdU, bromodeoxyuridine;  FBS, fetal bovine serum; FFU, focus-forming 
units;  HMW RNA, high  molecular  weight  RNA, ME,  mouse embryo;  Mo-MuLV,  Moloney leukemia 
virus; PBS, phosphate-buffered saline; PFU, plaque-forming units; SDS, sodium dodecyl sulfate; SSEA-1, 
stage specific embryonic antigen;  SSC, 0.15 M NaCI, 0.015 M sodium citrate; Tm, thermostability. 
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Materials and Methods 
Cells.  The teratocarcinoma-derived cell lines used in this study are listed in Table 1. The 
teratocarcinoma cell lines established in this laboratory were obtained as follows:  129 mice 
bearing OTT6050 tumors were received from Dr. Beatrice Mintz of the Institute for Cancer 
Research (Fox Chase, Pa.). Tumors were excised and observed for out growth in tissue culture 
in  RPMI  medium  (Flow Laboratories,  Inc., Rockville, Md.)  supplemented with  10%  fetal 
bovine serum  (FBS).  For establishing stem  cell  lines, cultures containing >50%  stem  cells 
(morphological criteria)  were split  at  high ratios  (1:50-1:100) until cultures were obtained 
which consistently retained the stem cell  morphology. Such cultures were mutagenized and 
selected in bromodeoxyuridine (BrdU). When colonies appeared, the concentration of drug was 
increased and clones were obtained which retained the stem cell morphology and were resistant 
to  100 ~g/ml BrdU. One such clone was designated OTT6050AF1 BrdU. Differentiated cell 
lines were obtained by selecting stem cell colonies and transferring these cultures at low split 
ratios  (1:5-1:10). All teratocarcinoma-derived cell lines established in this  laboratory were 
carried in RPMI medium with 10% FBS. All other cell lines used in this study were maintained 
in minimal essential medium supplemented with 10% FBS. Other cell lines used in this study 
were XC cells, a rat cell line used in the UV-XC plaque test  (16), for murine leukemia virus 
(MuLV); SC-1 cells (17), a feral mouse embryo cell line which is susceptible to replication of N- 
and B-tropic MuLV, (obtained from Dr. J. Hartley); 129ME, 129 GIx-ME, and C57BIME cell 
lines established from embryos of strain  129, 129 Glx- and C57BL/6 mice, respectively (K. 
Huebner, unpublished results);  primary cultures of BALB/c and NIH mouse embryo cells 
obtained from Flow laboratories; mink S+L-  (18) cells obtained from P.  Peebles, National 
Cancer Institute; mink lung cells obtained from the ATCC; HT1080 human fibrosarcoma cells 
(19); J1SV9  cells  (20); J1SV9  cells  producing B-tropic MuLV;  BALB-3T3 cells  (21);  and 
human tumor cell lines producing either class II or class III xenotropic MuLV (22) which were 
generously provided by Dr. S. Hino. 
Viruses.  NB tropic Mo-MuLV and N-, B°, and X-tropic MuLV seed stocks were obtained 
from Dr. J.  Hartley (NIAID). Ecotropic virus stocks  were grown in SC-1  cells or secondary 
cultures of NIH or BALB/c mouse embryo (ME) cells after seeding cells in polybrene (2 #g/ml) 
(23). Xenotropic BALB virus 2 (Class II virus from J. Hartley) and NZB (class III virus from 
A. Ishimoto) stocks were grown in mink lung cells or human cells seeded 24 h before infection 
in medium containing  polybrene (2/~g/ml). Ecotropic virus stocks were titered for XC-plaque- 
forming ability and usually had a tiler between 106 and 107 plaque-forming units (PFU)/ml; 
X-tropic virus was titered for focus-forming ability on mink S + L- cells (18) and stocks used 
had  titers of  104  focus-forming units (FFU)/ml. N-,  B-, and X-tropic viruses were  used  as 
controls when testing the tropism of the virus isolated from OTT6050 cell lines. 
XC Plaque  Test.  Supernatant fluids of viral stocks  to be assayed for XC-plaque-forming 
ability were  filtered and titrated as previously described (23),  by the UV-XC procedure of 
Rowe et al (16). SC-1  cells were routinely used in the plaque test  but if it was  necessary to 
determine the tropism of the ecotropic virus, NIH  (Fv-1 "n) and BALB/c (Fv-I bb)  secondary 
ME cultures were used. 
Mink S+ L-  Focus Assay.  Supernates or viral stocks to be titered for focus-forming  ability on 
mink S+L-  cells  were  filtered and 0.5  ml of each  sample with appropriate dilutions was 
inoculated into duplicate Petri dishes which had been seeded 24 h  previously with 3  ×  105 
mink S + L-- cells/dish in medium containing 2/tg/ml polybrene (24). After  1 h absorption, 
inocula were removed and 5 ml medium containing 10% FBS added. Medium was changed 
every 2 d and on day 8-10, foci were enumerated and FFU/ml calculated. 
Reverse Transcriptase Assay.  The assay procedure used was that described by Manly (25) with 
some modifications as described previously (23).  Reaction mixtures contained the following 
components in a 50-/xl final volume:Tris-hydrochloride  buffer, 50 mM, pH 8.3; NaC1, 60 mM; 
dithiothreitol, 20 mM; [~H]thymidine triphosphate, 21 ~M  1,600 epm/pmol; polyriboadenlyic 
acid, 50/~M; oligothymidylic acid, 5 mM; Nonidet P-40, 0.05%;  MnCI2, 1 mM, and  10 btl of 
sample to be tested. The reaction mixtures were incubated at 37°C for 60 min. Incorporation 
of [3H]thymidine triphosphate was determined by adsorption onto DEAE filters. Supernates of 
cells  to  be tested  for  reverse transcriptase activity were either tested  directly or a  100-fold 
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triphosphate incorporated per milliliter of supernate. 
lndirect lmmunofluorescent Staining for Detection of Cellular and Viral Antigens.  The following sera 
were used in indirect immunofluorescence  staining  of fixed or viable cells to determine ifMuLV 
antigens were  being produced:  (a)  Anti-Rauscher MuLV  gp69/71  (26),  (b)  Anti-Rauscher 
MuLV p30  (26),  (c)  Anti-AKR MuLV p30,  (d)  Anti-Gross MuLV gp69/71,  (e)  Anti-Gross 
MuLV p30.  Sera a and b were kindly supplied by Doctors Strand and August: sera c, d, and 
e  were  kindly supplied by  Dr. ,Jack  Gruber through  the  National Cancer  institute Viral 
Oncology  Resources  and  Services.  All  sera  were  produced  in  goats  against  purified  viral 
proteins. Fluorescein-conjugated rabbit anti-goat serum  (Antibodies Inc., Davis, Calif.)  was 
used as the second reagent in the indirect assay. Indirect immunofluorescence  on fixed cells was 
performed as follows: subconfluent cultures on coverslips  were fixed in acetone; the anti-viral 
sera were applied to coverslips, and incubated at 37°C in a humidified atmosphere for 30 min, 
after  which  coverslips  were  washed  extensively with  phosphate-buffered  saline  (PBS)  and 
fluorescein-conjugated  anti-goat serum applied for 30 rain at 37°C. After washing, the coverslips 
were counterstained with 0. I% solution of Evans blue. For surface immunofluorescence  of viral 
antigens, viable single cell suspensions were stained according to the procedure of Campbell et 
al. (27). Viable single cell suspensions were also stained for H-2 antigen and for the embryonic 
antigen of teratocarcinoma stem cells, SSEA-1, which is detected by the monoclonal antibody 
described by Knowles et al. (28) and Solter and Knowles (29). Mouse alloantisera D33 and D- 
2 reactive to the H-2 specificities  shown in Table II were obtained by B.  Knowles from the 
Transplantation  and Immunology  Branch, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, and were used at dilutions of 1  : I0 with fluorescent rabbit IgG 
specific for mouse IgG heavy and light chain as the second reagent (used at dilution of 1:10). 
Anti-SSEA-1 was  provided by D.  Solter and B.  Knowles and used at  a  dilution of 1: 1,000. 
Fluorescent goat IgG, specific for mouse IgM heavy chain, was used as the second reagent at a 
dilution of 1:10. 
Preparation of MuLVcDNA Probes.  cDNA probes were prepared from AKR N-tropic MuLV 
grown on SC-1  cells  and from  the virus produced by the differentiated cell  line, OTTF12. 
Virus was harvested at  12-h intervals, concentrated, and purified, and all-labeled cDNA was 
synthesized by the endogenous reaction of the purified virus in the presence of actinomycin D 
and DNase I-digested calf thymus DNA primer (30) and purified as described previously (31). 
The all-labeled cDNA was  hybridized with equal amounts of viral high  molecular weight 
(HMW) RNA and DNA-RNA hybrids (30-40%  of the input cDNA) formed fractionated by 
hydroxylapatite column chromatography and treated with NaOH to destroy RNA as described 
previously (31). The cDNA thus prepared had a sp act of 2  ×  10  7 cpm//tg. 
Preparation of Cellular DNA  and  RNA.  Cellular DNA  was  extracted  from  OTT6050AF1 
BrdU, PCC4, and O'VFF12 cells, AKR liver, and from 129/,J embryos. Tissue was rinsed with 
Dulbecco's PBS,  minced with a  pair of scissors, suspended in  10 vol of Tris-buffered saline- 
EDTA buffer (0.01 M Tris HCI, pH 7.0, 0.01 M EDTA, and 0.1 M NaCI), homogenized with 
a Virtis homogenizer (Virtis, Gardiner, N. Y.) at 0°C,  10,000 rpm for  10 min. After homoge- 
nization, sodium dodecylsulfate (SDS) and proteinase K  (Merck & Co., Inc., West Point, Pa.) 
were  added  to  1%  and  100  #g/ml,  respectively,  and  the  mixture was  incubated at  room 
temperature overnight. Cultured cells were washed with  PBS,  suspended in  10  vol  of STE 
buffer containing  proteinase K (100/tg/ml), disrupted by addition of SDS (final concentration: 
1%), and incubated at  room temperature overnight. Nucleic acids were extracted  from  the 
lysate with 80% phenol and chloroform and isoamyl alcohol (24:1 vol/vol), precipitated with 
2 vol of ethanol, and collected by a low speed centrifugation as described previously (32). The 
precipitated nucleic acid was suspended in V  buffer (0.01 M  Tris HCI, pH  7.0, 0.01 EDTA, 
and 0.5  M  NaC1). After the addition of 2 vol of glycerol, DNA was sheared with a  Virtis 
homogenizer (33) as described previously (32). Nucleic acids were collected by precipitation 
with ethanol, resuspended in 0.3 N NaOH, and the solution was incubated at 37°C overnight, 
and neutralized with acetic acid. After the addition of EDTA (10 mM), proteinase K  (100 ~g/ 
ml), and SDS  (1%), the solution was  incubated at  37°C for  1 h.  DNA was  extracted  with 
phenol and chloroform:isoamyl alcohol as  described above. The aqueous phase was  treated 
with  2  vol  water-saturated  ether,  and  DNA  was  precipitated  with  2  vol  of ethanol.  The 
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final precipitate was dissolved in a  small volume of 0.1  SSC (0.15  M  NaCI, 0.015  M  sodium 
citrate). The DNA solution thus obtained had an absorbancy ratio of >1.8 when absorbancies 
were compared at 260 and 280 nm. The concentration of DNA was calculated on the basis that 
20 U  of absorbancy at 260 nm is 1 mg/ml of DNA solution. For isolation of RNA, cells grown 
as monolayer cultures were treated with pronase (50/~g/ml), washed with PBS, and disrupted 
with  1%  SDS  in  the presence of proteinase K  (500  /tg/ml)  as described by Hayward  (34). 
Nucleic acid was extracted with phenol and digested with DNase I  as described previously, 
(35).  Viral HMW  RNA was prepared as described previously (36)  except that  after lysis of 
virions with  1% SDS, the lysate was treated with proteinase K  (500/tg/ml) at 20-25°C for 30 
min. 
Hybridization and Tm Analysis.  Mixtures of cellular DNA (3-5 mg/ml) and ['~H]cDNA (7,500 
cpm) were made in  150/~1 of 0.55 N  (Na  +) sodium phosphate buffer (pH 6.8)  containing 0.1% 
SDS and  1 mM EDTA.  10-/~1 aliquots were distributed into capillary tubes and incubated for 
various lengths of time at 66°C as described previously (32). The amount of hybrid formed was 
assayed by the batch elution method of hydroxylapatite as described previously (32) except (1) 
that  the  hybrid formed was eluted with  0.12  M  phosphate buffer containing 0.4%  SDS  at 
100°C and (2) that the radioaetivities in hybridized and unhybridized fractions were measured 
in a scintillation counter after the addition of aquasol (New England Nuclear) to each fraction. 
For [3H]cDNA and cellular or viral RNA hybridization, 5  ×  104 epm/ml of [3H]cDNA was 
mixed with RNA of a saturating concentration in 3  ×  SSC and 30% formamide. The mixture 
was incubated at  50°C  for 7 d  and  diluted '20-fold with  1  ×  SSC after the incubation. An 
equal portion of aliquots was incubated at 0, 50, 60,  70, 80, 85, 90, 95,  100°C  for  1 min and 
then quickly chilled in ice water. The amount of hybrid was quantitated by the S-1  nuclease 
method as described previously (36). rim analysis of hybrids between [3H]DNA and a saturating 
concentration of cellular DNA was done essentially by the methods described above, except 
that the solution of [aH]DNA and cellular DNA mixture was dialyzed against 1 ×  SSC before 
heat treatment. 
Results 
Sources and  Characterization of Teratocarcinoma-Derived Cell  Lines.  Teratocarcinoma- 
derived cell lines established in  this  laboratory and  those obtained  from  others are 
described in Materials and Methods and are listed in Table I with a  brief description 
and source of the cell line and/or  tumor.  The  first three cell lines listed in Table I 
(PCC4,  F9, and OTT-Brinster)  were established by other investigators from tumors 
derived from  the transplantable strain  129  OTT6050  tumor of Stevens. The  fourth 
cell line listed (FA-25) was established by D.  Solter from an AKR  embryo. All other 
lines  were  established  in  this  laboratory;  all  OTT6050  lines  established  in  this 
laboratory were derived from one tumor, OTT6050A.  Because, as will be seen in the 
following  experiments,  the  cell  lines  established  from  the  OTT6050A  tumor  had 
properties which are distinct from the properties of the F9 and PCC4  cell lines, two 
other  tumors  (OTT6050B  and  OTT6050C)  were  obtained  from  Dr.  Mintz  and 
studied  as  primary  tissue  cultures  to  be  sure  that  the  viral  expression  observed  in 
OTT6050A-derived  cell lines was  not  unique  to one  tumor.  In addition a  cell line, 
OTT-E, established and carried by Dr.  Solter from  the OTT6050A  tumor, was also 
studied. Because teratocarcinoma stem cells do not express H-2 antigens (37, 38, 39) 
but do express a stage-specific embryonic antigen (SSEA-1) which is not expressed by 
differentiated cells (28, 29), and the reverse is true for differentiated cell lines, we have 
used surface antigens as markers for characterization of our stem and differentiated 
cell lines. Using monoclonal antibody which  detects the specific embryonic antigen 
(SSEA-1)  on murine teratocarcinoma cells (28,  29)  and mouse anti-H-2K  b and anti- 
H-2D  b serum  we have stained the surfaces of our stem  and  differentiated cells and 396  VIRAL  DNA  IN  TERATOCARCINOMA-DERIVED  CELLS 
TABLE  I 
Origins and Characteristics of Teratocarcinoma-Derived Cell Lines 
Tumor origin and refer-  Source of cells 
Cell line  Description  ence for cell line 
Established by uther laboratories 
PCC4  Pluripotent stem cell line which remains undifferentiated in 
tissue culture 
F9  Nullipotent stem cell line which does not differentiate even 
in vivo 
OTT-Brinster  Mixed culture of stem and differentiated  cells established 
by D  Sober from tumor of R. Brinster 
Fa-25  Mixed culture of stem and differentiated  cells established 
by D. Soher 
Established in this laboratory  from O'1"I'6050 tumors from ICR* 
OTT6050AFI BrdU  Pluripotent stem cell clone which remains undifferentiated 
in tissue culture but is able to participate in formation of 
mosaic mice 
OTTFI2  (d)  Pluripotcnt  stem  (~9(}~7~ undifferentiated)  cell  line  from 
which OTT6050AFI  BrdU was cloned 
OTTS3,O'ITS4  Differentiated cell lines all established from one initial flask 
293S  of primary explanted tumor (flask 1) 
OTTF7  Differentiated  cell line established from Flask 7 of primary 
tumor cxplant 
OTTFI2  Differentiated cell line established from OT/'FI2  (d) 
OTT-E  Differentiated  cell  line  established  by  D.  Sober  from 
OTT6050A embryoid bodies 
Primary cultures from OTT6050 tumors from ICR 
OTI'-B  Primary embryoid body culture 
OTT-C  Primary tissue culture derived from solid tumor 
OTT6050 (2)  D. Soher 
OTT6050 (1)  D. Soher 
OTT6050  1). Soher 
AKR embryo (29)  D. Soher 
Oq~'6050A (6)  C, Croce 
(First  tumor  from  B. 
Mintz, ICR) 
OTT6050A  C. Croce 
OTT6050A  K. Huebner 
OTTf050A  K. Huebner 
OTT6050A  K. Huebner 
OTT6050A  D. Soher 
OTT6050B  M. Dewey  and B. 
(second  tumor  from  Mintz 
ICR) 
OTT6050C (third tumor  C. Croce 
from ICR) 
* ICR, Institute for Cancer Research. 
various control cells  as described  in Materials  and Methods  and have obtained  the 
results  presented  in  Table  II.  From  this  data  it  can  be  concluded  that  the 
OTT6050AF1  BrdU cells are 97% stem cells (because they are 97% positive for SSEA- 
1 antigen  and  <3%  positive  for H-2  antigen),  whereas  the  OTTF12  cells  are  99% 
differentiated because they are negative for SSEA-1  antigen and 99%  positive for H- 
2 antigen. 
Interaction of Teratocarcinoma-Derived Cell Lines with MuLV.  P~ri~s et  al.,  (13)  dem- 
onstrated  that  the  pluripotent  stem  cell  ine,  PCC4,  did  not  produce  viral  reverse 
transcriptase activity or infectious virus after infection with Mo-MuLV, Gross MuLV, 
or  Friend  MuLV  nor  did  these  stem  cells  undergo  morphological  changes  after 
infection  with  Moloney murine sarcoma virus  (Mo-MuSV).  Teratocarcinoma  (em- 
bryoid  body)-derived  differentiated  cell  lines,  on  the  other  hand,  were  capable  of 
producing each of the above MuLV's and were susceptible to transformation by Mo- 
MuSV.  Teich  et  al.  (14)  using  another series of teratocarcinoma-derived  stem  and 
differentiated  cell  lines  demonstrated  that  the  teratocarcinoma-derived  undifferen- 
tiated  (nulli and pluripotent stem cells) cells were entirely nonpermissive for produc- 
tion  of Mo-MuLV  although  virus  adsorption  and  penetration  were  not  restricted. 
After infection of the pluripotent stem cell line, proviral DNA sequences were detected 
but  transcription  into viral RNA was not detected.  Very early in our studies of cell 
lines  established  from  the  OTT6050A  tumor,  we  observed  reverse  transcriptase 
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TABLE II 
Presence of Serotogically Detectable H-2 and SSEA-I Antigens on Stem and Differentiated Celt Lines 
Percentage positive by immunofluores- 
cence 
Mouse strain and H-2  Target cells  Anti-SSEA- 
type  Anti-H-2K  b  Anti-H-2D  b  1 mono- 
(33)  (2)  clonal anti- 
body 
F9-stem  129 H-2  ~  < 1  < 1  99 
OTT6050AF1  BrdU  129 H-2  b¢  <3  <3  97 
(stem) 
OTTF12 (differentiated)  129 H-2  ~  99  99  0 
FA-25 (stem and differen-  AKR H-2  k  <3  <3  76 
tiated) 
BALB-3T3 fibroblasts  BALB H-2  a  < 1  < 1  0 
129 ME fibroblasts  129 H-2 b~  80  85  0 
and  differentiated  cell  lines,  and  mixed  cultures  of stem  and  differentiated  cells 
derived from  the OTT6050A  tumor  in  this  laboratory were  tested  for spontaneous 
expression  of C-type  viral  functions.  To  be  certain  that  spontaneous  C-type  viral 
expression was not  a  result of laboratory contamination of our cell lines, a  cell line 
derived from OTT6050A  and maintained by D.  Solter in a  different laboratory was 
also  tested,  as  were  primary  cells  from  two  subsequent  tumors,  OTT6050B  and 
OTT6050C,  obtained from ICR (the same source as for the OTT6050A tumor) which 
consisted of mixed cultures of stem and differentiated cells. Results of tests for C-type 
viral expression (spontaneous or after infection by Mo-MuLV)  are given in Table III. 
Culture  medium  collected  from  uninfected  and  infected  cells  were  tested  for  the 
presence of reverse transcriptase activity, infectious virus (by XC-plaque assay) and 
the  infected  and  uninfected  cells were  tested  for  production  of viral  antigens  (by 
indirect immunofluorescence) as described in the legend for Table III. Results of these 
tests are summarized in Table III. The stem cell lines F9 and PCC4 were resistant to 
productive infection by all three criteria. The cell lines derived from  the OTT6050- 
ICR tumors gave somewhat different results. The differentiated cell lines derived from 
the OTT6050A-ICR  tumor were spontaneously producing MuLV  which formed XC 
plaques  on  SC-1  cells.  In  addition,  the  stem  line  (OTTF12  (d)),  primary  tumor 
explants,  and  embryoid  body  cultures  all  showed  some  evidence  of production  of 
MuLV, as detected by reverse transcriptase activity or by XC-plaque assay. Only the 
OTT6050AF1  BrdU cell line which is >97% undifferentiated was completely negative 
for virus expression by all three criteria. The evidence presented in the summary of 
results in Table III suggested the possibility that  the stem cells of OTT6050  tumors 
from ICR contain MuLV  in a  suppressed state which on differentiation is expressed 
as infectious virus. 
Characterization  of MuLV  Produced  by  OTT6OSO-ICR  Tumor-Derived  Cell  Lines.  To 
determine its host range, the virus isolated from differentiated lines derived from the 
OTT6050A  tumor was  used  to infect cells of Fv-1  n~ and  Fv-1 bb genotype and mink 
cell lines. The results of this experiment are summarized in Table IV. The virus did 
not  replicate  in  other  teratocarcinoma  stem  cell  lines,  nor  did  it  produce  reverse 
transcriptase  activity after  infection  of mink  S+ L-  cells or  after  cocultivation  of 398  VIRAL  DNA  IN  TERATOCARCINOMA-DERIVED  CELLS 
TABLE  III 
MuL V Infection  of Teratocarcinoma-Derived  Cell Lines 
Cell lines  Infected with 
Reverse  Titer  Expression of 
tran-  logl0 on 
sciptase  SC- 1  gp69/7 !  gp69/71 
activity  cells  surface  cytoplasmic 
p30 
pmol/rnl  PFU/ml 
of supernate 
From other laboratories 
PCC4  No virus  <0.1  0.0  -  -  - 
+  Mo-MuLV  <0.1  0.0  -  -  - 
F9  No virus  <0.1  0.0  -  -  - 
+  Mo-MuLV  <0.1  0.0  -  -  - 
OTT-Brinster  No virus  <0.1  0.0  -  -  - 
+  Mo-MuLV  NT  NT  -  NT  NT 
From OTT6050  tumors from ICR 
OTT6050AFI  BrdU  No virus  <0.1  0.0  -  -  - 
Stem  +  Mo-MuLV  <0.1  0.0  NT  -  - 
OTTFI2  (d)  No virus  0.4  1.3  few  +  few  +  few  + 
Mostly stem  +  M0-MuLV  .08  NT  NT  NT  NT 
2935  /  No virus  10.7  4.6  +  +  +  +  +  +  +  +  +  +  +  +  / 
+  Mo-MuLV  5.3  NT  NT  NT  NT 
OTT-E  Diff.  No virus  17.6  NT  NT  NT  NT 
OTTF7  No virus  37.3  4.6  +  +  +  +  +  +  + 
+Mo-MuLV  11.0  NT  NT  +  +  +  + 
OTTFI2  No virus  40.0  4.5  +  +  +  +  +  +  + 
OTT-B  ]  Primary  No virus  6.0  3.0  NT  NT  NT 
Stem and 
OTT-C  Diff.  No virus  2.0  2.3  NT  NT  NT 
Controls 
BALB/c  ME  No virus  <0.1  0.0  -  -  - 
+Mo-MuLV  76.6  6.0  +  +  +  +  +  +  +  +  +  +  +  + 
129GIx-ME  No virus  <0.1  0.0  -  -  - 
+Mo-Mulg  54.3  5.6  +  +  +  +  +  +  +  +  +  +  +  + 
NT, not tested. ICR, Institute for Cancer Research. 
Infection.  Cells to be tested were seeded in quadruplicate at a  density of 2  ×  l0  s cells/flask (75 cm  2)  in 
medium  containing 2 pg/ml  polybrene and 24 h  later, two flasks (for each cell line) were infected with  1 
PFU/cell  Mo-MuLV  and  two  flasks were  mock  infected.  Cells  were then  cultured  for up  to  2  wk and 
supernates were collected, filtered, and frozen every 2 d. After the last collection of supernate, infected and 
uninfected  cells  were  trypsinized  and  tested  for expression  of C-type viral antigens  as  described  below. 
Aliquots  of  unconcentrated  supernates  were  tested  for  plaque-forming  MuLV  on  SC-I  cells  and  the 
remainders of the supernates were concentrated  100-fold and tested for reverse transcriptase activity. Each 
cell  line  was tested  at  least  three  times;  results  shown  in  the  table  are  from a  single experiment  but  all 
results were consistent with those shown. 
Viral Antigens.  After the last collection of supernates, cells were trypsinized and either stained directly 
(as viable cells) in suspension by indirect immunofluorescence for expression of surface gp69/71 using anti- 
Rauscher  MuLV  gp69/71  or  were  seeded  in  Petri  dishes  with  coverslips  for  fixation  and  tested  for 
cytoplasmic viral antigens by indirect immunofluorescence. 
All  results  in  the  table  were  obtained  using  anti-Rauscher  MuLV  gp69/71  and  p30  (sera  a  and  b 
described  in  Materials and  Methods)  but  similar results were obtained  using anti-Gross MuLV  gp69/71 
and p30 (sera c, d, and e, described in Materials and Methods). HUEBNER, TSUCHIDA,  GREEN,  AND  CROCE 
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Source of virus 
Reverse transcriptase activity 
[Titer 
[Titer Log10] XC  logl0] 
plaque (PFU/ml) on  FFU/ml 
on 
Mink 
PCC4  F-9  Mink  NIH-  BALB/c-  S + L- 
lung  ME  ME 
cell 
pmol/ml of supernate 
OTTF7  <0.1  <0.1  <0.1  4.6  2.3  0 
OTTFI2  <0.1  <0.1  <0.1  4.9  2.8  0 
OTT-C  NT  NT  NT  I. 1  0  NT 
OTT-E  NT  NT  NT  3.7  1.7  NT 
OTTS4  NT  NT  NT  4.3  2.0  0 
Controls 
Mink/NZB  (producing  NT  NT  11.0  0  0  4.0 
X-tropic virus) 
BALB/c ME/B-MuLV  NT  NT  <0.1  2.0  4.0  0 
NIH ME/N-MuLV  NT  NT  <0.l  6+0  4.0  0 
Supernates of cell lines on the left were filtered and inoculated into cultures (listed across the top of the 
table)  which had been seeded previously  in medium containing polybrene (2/tg/ml). Each cell line was 
treated in this way two or more times and results were similar;  results given in this table are from a single 
experiment. 
Reverse Transcr~ptase Assay.  Supernates were collected  from infected cells every other day for 2 wk, and 
supernates were pooled, concentrated, and assayed for reverse transcriptase activity. 
XC-Plaque Assay.  Petri  dishes,  seeded  previously  in  medium  containing 2  /tg/ml  polybrene, were 
inoculated with appropriate dilutions of the virus-containing supernates and later irradiated and overlaid 
with XC cells as described in Materials and Methods. Virus was also assayed on  129G~x-ME (Fv-1"") and 
on C57BIME (Fv-1  ~) cells with similar results. 
Focus Assay.  To  determine if xenotropic virus  was  present, mink  S+L-  cells  were  infected with 
appropriate dilutions of virus containing supernates and observed for loci of transformed cells. 
Infectious Center Assay and Cocultivation Experiments.  To increase the sensitivity  of the assays for biological 
activity of virus, the cell lines listed on the left were treated with mitomycin C and then seeded directly 
onto monolayers of NIHME, BALB/c ME, and mink S + L- cells and developed as for XC-plaque assay 
or a mink S+ L- assay. In every case, the infectious center assay results agreed with those obtained from 
tests  of the virus-containing supernates. From infectious  center assays it  was possible  to determine that 
>90~7~ of cells in the OTTF7 and OTTFI2 cell lines were producing virus. For cocultivation experiments, 
mitomycin C-treated cells were seeded with mink lung celts and supernates were  taken every  2 d  for a 
month; supernates were then pooled, concentrated, and tested for reverse transcriptase activity.  The virus 
derived from the OTT6050A-derived lines did not show xenotropic virus activity by any of these assays. 
OTTF7  cells  with  mink  lung  cells  (Table  IV)  and  thus  contains  no  detectable 
xenotropic or amphotropic  virus. It is ecotropic and grows preferentially in cells of the 
Fv-1 n" genotype. Virus was collected from supernatant  medium  of the OTTF12  cells 
and from AKR  N-tropic MuLV  producing SCo 1 cells and [3H]cDNA probes, prepared 
as described in Materials and Methods. These two cDNA  probes were then compared 
for homology to each of the respective high molecular weight  viral  RNA's  from the 
purified virus preparations. In addition, these cDNA's  were hybridized with cellular 
RNA  extracted from the differentiated cell lines, 293S  and OTTF12,  and with RNA 
from  HT1080  human  cells and  thermostabilities (Tm's)  of the cDNA/RNA  hybrids 
were determined. Results of the comparison of these two viruses are given in Table V. 400  VIRAL  DNA IN TERATOCARCINOMA-DERIVED  CELLS 
TABLE V 
Comparison of Nucleotide Sequences of AKR N-Tropic MuL V and N-Tropic MuL V Produced by 
OTT605OA-Differentiated Cell Lines 
[:~H  Icl)NA  fi'om 
Source of RNA  AKR N-tropic  MuI.V  OTTF 12 N-tropic  MuI.V 
Hybridization*  T~, (°C)  Hybridization  T., (°C) 
AKR  N-tropic MuLV  100*  85 
HMW 
OTTFI2 MuLV HMW  >95  84.5 
293S cells 
OTTF 12 cells  >95  84 
PCC4 cells  29  79 
129 embryo 
J1SV9  cells producing  >95  85 
B-tropic virus 
Human  cell producing  80  81 
class  II  xenotropic 
MuLV 
Human  cell producing  43  79 
class  III  xenotropic 
MuLV 
HTI080 cells  <5 
'7, 
>95  85 
100  85 
>95  85 
29  79 
70  80.5 
<5 
[aH]cDNAs were prepared from the endogenous N-tropic virus of AKR mice and from the virus  produced 
by the OTT6050A-derived  differentiated cell line, OTTF  12, and hybridized to saturating levels  with RNA. 
The amount of hybrid formed was determined by the S-1 nuclease method (41). Tm determinations were 
carried out as described in Materials and Methods. 
* The level of hybridization between [3H]cDNA and the homologous HMW viral RNA was normalized to 
t00%; the actual saturation level was >90%. 
As can be seen from the data presented in this table the hybridization saturation level 
of the eDNA's with the  HMW  viral RNA from  the heterologous N-tropic virus or 
with  RNA from cells producing the heterologous N-tropic virus was >95% and the 
Tm's for the eDNA/HMW  viral RNA hybrids were essentially the same whether the 
eDNA was hybridized to the homologous or heterologous HMW N-tropic viral RNA. 
In contrast, the hybridization saturation levels of thee eDNA's with RNA from cells 
producing class  II  and class  III viruses is  lower and the Tm's of the  latter  type of 
cDNA/RNA  hybrids are  much lower.  We conclude from this comparison that  the 
two  viruses,  N-tropic virus from  AKR  mice  and  N-tropic  virus from  OTT6050A- 
derived differentiated cells are indistinguishable  on the basis of biological properties 
and molecular hybridization studies. 
Viral  DNA  Sequences  in  OTT605OA-Derived  Stem  and Differentiated  Cell  Lines.  The 
results presented above suggested that stern cells derived from the OTT6050A tumor 
may  carry  suppressed  N-tropic  MuLV  genomes.  To  test  this  possibility, cellular 
DNA's were extracted from OTT6050AF1 BrdU, OTTF12, and PCC4 cells, and from 
AKR  liver  tissue,  and  129/J  embryo  tissue,  and  hybridized  with  AKR  N-tropic 
MuLV  [3H]eDNA. As shown in Fig.  1, OTT6050AF1 BrdU  DNA hybridized to as 
high a  saturation level (73%) as did DNAs from AKR liver and OTTF12 cells, both 
of which carry N-tropic MuLV genomes. On the other hand, the DNA's from  129/J 
embryo tissue and the PCC4 cells from which no ecotropic virus has been isolated, HUEBNER, TSUCHIDA,  GREEN,  AND CROCE 
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FIG.  1.  Hybridization of cellular DNA with AKR N-tropic MuLV  I3H]cDNA. [3H]cDNA was 
hybridized with cellular DNAs from OTT6050AFI BrdU (5.1 mg/ml, A), OTTFI2 (4.2 mg/ml, 
A), PCC4 (4.4 mg/ml, O), AKR liver tissue (3.8 mg/ml Y), and 129/J embryo tissue (3.8 mg/ml, 
O)  in capillary tubes as described in Materials and Methods. The extent of hybridization was 
determined by the hydroxylapatite batch elution method. Cot is the product of the initial concen- 
tration of DNA (tool/liter) and the incubation time (s) as defined by Britten and Kohne (40). 
TABLE VI 
Thermostability of Hybrids between Cellular DNAs and cDNAs 
DNA source 
Tm (°C) of hy-  Tm (°C) of hy- 
brid with AKR  brid with 
N-tropic MuLV  OTTF12 MuLV 
cDNA  cDNA 
OTT6050AFI BrdU cell  81.5  82 
OTTF12 cell  81  81.5 
Human  cell-producing class  77.5 
II xenotropic virus 
PCC4 cell  77.5  76.5 
hybridized only to  the  50%  level.  In addition, as shown  in Table VI,  the  hybrids 
between the OTT6050A derived cellular DNAs (from both OTT6050AF1 BrdU and 
OTTF12)  and  the  cDNAs  from  both  AKR  N-tropic  MuLV  or  OTTF12  derived 
MuLV have higher Tm's than do the hybrids between PCC4 cellular DNA and the 
same two cDNA's. The results of these molecular hybridization and thermal denatur- 
ation studies demonstrate that the OTT6050A-derived stem cell line, OTT6050AF1 
BrdU,  contains N-tropic  MuLV-related  DNA sequences which  are  not  present  in 
PCC4 or  129/J embryo-derived DNA. It can also be estimated from the C0tx/2 values 
of Fig.  1 that  the  DNA  of the  stem  cell  line, OTT6050AF1  BrdU,  contains more 
copies of the N-tropic AKR virus related DNA sequences than does the DNA derived 
from the differentiated cells, OTTF12, 100% of which produce N-tropic MuLV. 402  VIRAL  DNA  IN  TERATOCARCINOMA-DERIVED  CELLS 
Discussion 
We have described a set of murine teratocarcinoma derived stem and differentiated 
cell lines which we believe will be extremely useful in the study of the mechanism of 
control of viral gene expression in stem cells. 
The stem cell line, OTT6050AF1  BrdU, consists of 97% undifferentiated cells and 
is completely negative for spontaneous expression of ecotropic routine leukemia virus 
by reverse transcriptase assay and XC-plaque assay of supernatant  medium and for 
expression  of  viral  protein  by  indirect  immunofluorescence.  The  stem  cells  do, 
however, contain  DNA sequences homologous to an  N-tropic MuLV cDNA probe. 
Because none of the cells in the stem cell line shows any evidence of virus production, 
it is very unlikely that the presence of these DNA sequences could be explained by 
productive infection of a few cells in the culture, especially because the stem cell line 
carries more copies of these DNA sequences than do the cells of the differentiated cell 
line OTTF12,  100% of which are positive for viral protein expression and which are 
producing  N-tropic  MuLV.  Thus,  we  have  the  ideal  set  of cells  for  the  study  of 
regulation of expression of genes in stem versus differentiated cells because the cells 
contain a set of genes (N-tropic viral genes), present in both the stem and differentiated 
cells, for which transcription and/or translation is differentially regulated in the two 
cell types. 
These viral DNA sequences are probably not  sequences of a  virus endogenous to 
strain 129 mice because the DNA/DNA hybrids between PCC4 cellular DNA and N- 
tropic MuLV cDNA have a themal stability which is lower than that of DNA/DNA 
hybrids of OTT605AF1  BrdU cellular DNA with  the N-tropic MuLV cDNA.  The 
route of introduction  of this viral DNA into the teratocarcinoma tumor cells is not 
known  but  we  believe  that,  regardless  of the  origin  of the  virus  and  the  route  of 
introduction  into the cells, these cell lines will provide a  valid model for the study of 
regulation of expression of ecotropic MuLV in stem versus differentiated cells. 
It is not yet known if all differentiated cells express the virus (if only a  few did, the 
infection would spread since the cells of strain  129  mice are permissive for N-tropic 
MuLV)  and when after differentiation the virus is expressed (probably not immedi- 
ately because the stem cell line is not  100% free of differentiated cells and yet it is not 
possible to detect infectious virus in these cells even by cocultivation with NIH ME 
cells). 
We are presently testing various agents which are known to induce virus production 
and/or  differentiation  in  other  systems  (such  as  Friend  erythroleukemia  cells)  to 
determine  if and  when  the  N-tropic virus  is  produced  after differentiation  of stem 
cells.  In addition, because chimeric mice are being produced with this stem cell line, 
and hybrids derived from it (6, 42), we will have an opportunity to follow expression 
of the N-tropic virus in vivo. 
Summary 
Murine teratocarcinoma stem cells are nonpermissive for productive infection by a 
variety of DNA (polyoma and SV40 virus) and RNA (murine leukemia and sarcoma 
virus)  tumor viruses whereas differentiated murine cells derived  from the stem cells 
are permissive for productive (or abortive in the case of SV40) infection by these same 
viruses. The block to productive infection by these oncogenic viruses is at  a  postpe- 
netration step in the replication cycle of these viruses but the precise level of the block HUEBNER,  TSUCHIDA, GREEN,  AND CROCE  403 
has not been established  for any of these viruses. In this report we describe teratocar- 
cinoma-derived stem and differentiated cell lines which should be especially useful in 
determining  the level of the block to replication  of ecotropic murine  leukemia  virus 
in murine teratocarcinoma stem cells. The stem cell line, OTT6050AFI BrdU, which 
is  completely  nonpermissive  to  productive  infection  by  Moloney  murine  leukemia 
virus  and  consists  of 97%  pluripotent  stem  cells,  contains  DNA copies  of an  RNA 
tumor  virus which  is  indistinguishable  from the  N-tropic  murine  leukemia  virus of 
AKR  mice.  The stem cells are  negative  for expression  of viral  reverse  transcriptase, 
p30 and gp69/71  and no virus is found by XC plaque assay or other biological tests. 
Differentiated  cells  established  from  the  same  teratocarcinoma  tumor  are  100% 
positive  for viral  gp69/71,  p30, and  produce  large  amounts  of reverse  transcriptase 
activity and N-tropic virus as detected by biological assay. The virus isolated from the 
differentiated cells is closely related, if not identical to AKR N-tropic virus by nucleic 
acid hybridization  studies  and  is  thus  not  an endogenous  virus of the  129 strain  of 
mice. The teratocarcinoma tumor from which the cell lines were established had been 
carried in 129 mice and perhaps at some time in the mouse passage history the tumors 
were infected  (nonproductively)  with  the N-tropic virus.  Regardless of the origin of 
this  viral  DNA, the OTT6050A derived  stem and differentiated  cell  lines should be 
extremely useful in defining in stem cells the step at which ecotropic murine leukemia 
virus replication  is blocked. 
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